The Prevalence of <i>TET2</i> Gene Mutations in Patients with <i>BCR</i>-<i>ABL</i>-Negative Myeloproliferative Neoplasms (MPN): A Systematic Review and Meta-Analysis
Multiple recurrent somatic mutations have recently been identified in association with myeloproliferative neoplasms (MPN). This meta-analysis aims to assess the pooled prevalence of <i>TET2</i> gene mutations among patients with MPN. Six databases (PubMed, Scopus, ScienceDirect, Google S...
Main Authors: | Yuh Cai Chia, Md Asiful Islam, Phil Hider, Peng Yeong Woon, Muhammad Farid Johan, Rosline Hassan, Marini Ramli |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/12/3078 |
Similar Items
-
Molecular pathogenesis of the myeloproliferative neoplasms
by: Graeme Greenfield, et al.
Published: (2021-06-01) -
The Epidemiology of Myeloproliferative Neoplasms in New Zealand between 2010 and 2017: Insights from the New Zealand Cancer Registry
by: Chris Varghese, et al.
Published: (2021-04-01) -
Clinical meaning of JAK2 V617F mutation in chronic myeloproliferative disorders – the first experience
by: Joško Vučković, et al.
Published: (2006-10-01) -
The ruxolitinib effect: understanding how molecular pathogenesis and epigenetic dysregulation impact therapeutic efficacy in myeloproliferative neoplasms
by: Graeme Greenfield, et al.
Published: (2018-12-01) -
The janus kinase 2 (JAK2) mutation: A review of its role in polycythaemia vera and other myeloproliferative disorders
by: M U Nwagu
Published: (2011-01-01)